Catalent, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
February 18 2020 - 3:05PM
Business Wire
Catalent, Inc. (NYSE:CTLT), the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, gene therapies, and consumer health
products, today announced that Wetteny Joseph, Senior Vice
President & Chief Financial Officer, will present at the 9th
Annual SVB Leerink Global Healthcare Conference at 10:00 a.m. ET on
Tuesday, February 25, 2020 in New York City.
A live webcast of the presentation will be accessible through
the Company’s website at http://investor.catalent.com and will be
available for replay following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE:CTLT) is the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, gene therapies, and consumer health
products. With over 85 years serving the industry, Catalent has
proven expertise in bringing more customer products to market
faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs more than
13,000 people, including approximately 2,400 scientists, at more
than 35 facilities across four continents and in fiscal 2019
generated over $2.5 billion in annual revenue. Catalent is
headquartered in Somerset, N.J. For more information, please visit
www.catalent.com.
More products. Better treatments. Reliably
supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200218006072/en/
Investors: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Apr 2024 to May 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From May 2023 to May 2024